Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type
Author:
Affiliation:
1. Janssen Scientific Affairs, LLC, Horsham, PA, USA
2. IQVIA, Durham, NC, USA
3. NeoGenomics, Fort Myers, FL, USA
Publisher
Informa UK Limited
Subject
Health Policy
Link
https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2309838
Reference40 articles.
1. Cancer Stat Facts: Lung and Bronchus Cancer. National Cancer Institute: Surveillance Epidemiology and End Results Program. Accessed July 2023. https://seer.cancer.gov/statfacts/html/lungb.html
2. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
3. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
4. Lung Cancer Survival Rates. American Cancer Society. Accessed 4/5 2023. https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/survival-rates.html
5. Zhang Y-L Yuan J-Q Wang K-F et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget . 2016;7(48):78985.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3